Caribou Biosciences, Inc. - Net Worth and Insider Trading
Caribou Biosciences, Inc. Net Worth
The estimated net worth of Caribou Biosciences, Inc. is at least $89 Million dollars as of 2024-09-20. Caribou Biosciences, Inc. is the 10% Owner of Intellia Therapeutics Inc and owns about 3,994,355 shares of Intellia Therapeutics Inc (NTLA) stock worth over $89 Million. Details can be seen in Caribou Biosciences, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Caribou Biosciences, Inc. has not made any transactions after 2018-01-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Caribou Biosciences, Inc.
Caribou Biosciences, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Caribou Biosciences, Inc. owns 1 companies in total, including Intellia Therapeutics Inc (NTLA) .
Click here to see the complete history of Caribou Biosciences, Inc.’s form 4 insider trades.
Insider Ownership Summary of Caribou Biosciences, Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2018-01-29 | 10 percent owner |
Caribou Biosciences, Inc. Latest Holdings Summary
Caribou Biosciences, Inc. currently owns a total of 1 stock. Caribou Biosciences, Inc. owns 3,994,355 shares of Intellia Therapeutics Inc (NTLA) as of January 29, 2018, with a value of $89 Million.
Latest Holdings of Caribou Biosciences, Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2018-01-29 | 3,994,355 | 22.22 | 88,754,568 |
Holding Weightings of Caribou Biosciences, Inc.
Caribou Biosciences, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Caribou Biosciences, Inc. has made a total of 0 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years. The most-recent trade in Intellia Therapeutics Inc is the sale of 550,645 shares on January 29, 2018, which brought Caribou Biosciences, Inc. around $15 Million.
Insider Trading History of Caribou Biosciences, Inc.
- 1
Caribou Biosciences, Inc. Trading Performance
Caribou Biosciences, Inc. Ownership Network
Caribou Biosciences, Inc. Owned Company Details
What does Intellia Therapeutics Inc do?
Who are the key executives at Intellia Therapeutics Inc?
Caribou Biosciences, Inc. is the 10 percent owner of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Technical Officer Eliana Clark , EVP & Chief Scientific Officer Laura Sepp-lorenzino , and EVP & Chief Business Officer Derek Hicks .
Intellia Therapeutics Inc (NTLA) Insider Trades Summary
Over the past 18 months, Caribou Biosciences, Inc. made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 10,373 shares made by Eliana Clark , a net sale of 2,397 shares made by Muna Bhanji , and a net sale of 7,807 shares made by Laura Sepp-lorenzino .
In summary, during the past 3 months, insiders sold 405 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 405 shares. During the past 18 months, 60,195 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 60,195 shares.
Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intellia Therapeutics Inc Insider Transactions
Caribou Biosciences, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Caribou Biosciences, Inc.. You might contact Caribou Biosciences, Inc. via mailing address: 2929 7th Street, Suite 105, Berkeley Ca 94710.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
